Technology

ARCA biopharma

$4.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.22%) Today
+$0.03 (+0.64%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ARCA biopharma and other stocks, options, and ETFs commission-free!

About ABIO

ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO. The listed name for ABIO is ARCA biopharma, Inc. Common Stock.

CEO
Michael R. Bristow
Employees
13
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
43.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
705.26K
High Today
$4.75
Low Today
$4.59
Open Price
$4.69
Volume
807.42K
52 Week High
$22.00
52 Week Low
$2.21

Collections

ABIO Earnings

-$1.14
-$0.76
-$0.38
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 16, Pre-Market

You May Also Like

CMDY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure